Screener
Acadia Pharmaceuticals ACAD Q1 2025 earnings
Reported May 7, 2025 · After market close
Revenue$244.3MBeat by $5.3M
EPS$0.11Beat by $0.01
Revenue estimate$239.0M
EPS estimate$0.10
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$332.3M
EPS estimate$0.21
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Acadia Pharmaceuticals report Q1 2025 earnings?
- Acadia Pharmaceuticals (ACAD) reported Q1 2025 earnings on May 7, 2025 after market close.
- What were Acadia Pharmaceuticals's Q1 2025 revenue and EPS?
- Acadia Pharmaceuticals reported revenue of $244.3M and eps of $0.11 for Q1 2025.
- Did Acadia Pharmaceuticals beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $239.0M by $5.3M. EPS beat the consensus estimate of $0.10 by $0.01.
- How did Acadia Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 18.7% from $205.8M a year earlier and eps grew 10.0% from $0.10.
- Where can I find Acadia Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-065672) and the 10-Q periodic report (0000950170-25-066231) directly on SEC EDGAR. The filing index links above go to sec.gov.
